Riik: Suurbritannia
keel: inglise
Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Flucloxacillin magnesium; Ampicillin trihydrate
Alliance Healthcare (Distribution) Ltd
J01CA51
Flucloxacillin magnesium; Ampicillin trihydrate
25mg/1ml ; 25mg/1ml
Oral suspension
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010103
PACKAGE LEAFLET INFORMATION FOR THE USER Co-fluampicil 125mg/125mg/5ml Powder for Oral Suspension Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or nurse. This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours The name of your medicine is Co-fluampicil 125mg/125mg/5ml Powder for Oral Suspension. In the rest of this leaflet it is called Co-fluampicil Suspension In this leaflet: 1. What co-fluampicil Suspension is and what it is used for 2. Before you take Co-fluampicil Suspension 3. How to take Co-fluampicil Suspension 4. Possible side effects 5. How to store Co-fluampicil Suspension 6. Further information 1. WHAT CO-FLUAMPICIL SUSPENSION IS AND WHAT IT IS USED FOR Co-fluampicil Suspension contains two active ingredients, ampicillin and flucloxacillin which together are known as co-fluampicil. Co-fluampicil Suspension is an antibiotic medicine. It belongs to the penicillin group of antibiotics and work by killing bacteria that cause infections. Co-fluampicil Suspension is used to treat a wide range of infections caused by bacteria. These infections may affect the chest, ear, nose, throat, skin and soft tissues. In hospital this medicine may also be used to prevent and treat infections: which occur after surgery in patients receiving treatment which affects the immune system of the blood (septicaemia) associated with difficulties in childbirth (septic abortion (abortion complicated by fever, often leading to sepsis) and puerperal fever (an infection of the membrane of the uterus following childbirth or abortion). 2. BEFORE YOU TAKE CO-FLUAMPICIL SUSPENSION Do not take Co-fluampicil Suspension if you: know that you are allergic to penicillin, cephalosporins, any other antibiotic or any of the ingredients contained in Co-fluampicil Suspension (see ‘What Co Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Magnapen ® 125mg/125mg/5ml Powder for Oral Suspension_ _ or Co-fluampicil 125mg/125mg/5ml Powder for Oral Suspension_ _ 2 QUALITATIVE AND QUANTITATIVE COMPOSITION When reconstituted each 5ml contains 125 mg ampicillin as Ampicillin Trihydrate BP with 125 mg flucloxacillin as Flucloxacillin Magnesium BP (co-fluampicil 125/125). 3 PHARMACEUTICAL FORM Bottle containing powder for the preparation of l00 ml suspension. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Co-fluampicil is indicated for the treatment of severe infections where the causative organism is unknown, and for mixed infections involving β _-_lactamase-producing staphylococci. Typical indications include: _In general practice: _Chest infections, ENT infections, skin and soft tissue infections, and infections in patients whose underlying pathology places them at special risk. _In hospital _(prior to laboratory results being available): severe respiratory tract infections, post-operative chest and wound infections, septic abortion, puerperal fever; septicaemia, prophylaxis in major surgery, infections in patients receiving immuno-suppressive therapy. The spectrum of activity of co-fluampicil also makes it suitable for the treatment of many mixed infections, particularly those where β -lactamase-producing staphylococci are suspected or confirmed. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION USUAL ADULT DOSAGE (INCLUDING ELDERLY PATIENTS AND CHILDREN OVER 10 YEARS): _Oral: _l0 ml syrup four times a day. USUAL CHILDREN’S DOSAGE: _Oral: _Under 10 years: 5 m1 syrup four times a day. The above dosages for adults and children may be doubled where necessary. Oral doses should be administered half to one hour before meals. 4.3 CONTRAINDICATIONS Co-fluampicil contains ampicillin and flucloxacillin which are penicillins, and should not be given to patients with a history of hypersensitivity to β -lactam antibiotics (e.g. penicillins, cephalosporins) or excipients. Co-fluampicil is contraindi Lugege kogu dokumenti